报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2025-03-31 | 56.49% | -14.41% | -18.38% | 60/158 | 32.3% | 艾力斯 | 96.74% | 行业排名> |
2024-12-31 | 69.21% | -14.81% | 1.92% | 34/158 | 51.8% | 首药控股 | 98.96% | 行业排名> |
2024-09-30 | 67.91% | -15.22% | 1.15% | 35/158 | 22.73% | 迪哲医药 | 97.73% | 行业排名> |
2024-06-30 | 67.13% | -14.17% | 1.71% | 36/158 | 33.18% | 百利天恒 | 97.99% | 行业排名> |
2024-03-31 | 66% | -22.8% | -18.77% | 35/158 | 51.56% | 百利天恒 | 98.92% | 行业排名> |
2023-12-31 | 81.25% | -4.24% | 1.44% | 21/158 | 51.38% | 迈威生物 | 98.93% | 行业排名> |
2023-09-30 | 80.09% | -5.93% | 2.4% | 25/158 | 32.56% | 迈威生物 | 99.59% | 行业排名> |
2023-06-30 | 78.22% | -8.2% | -8.51% | 25/158 | 38.45% | 迈威生物 | 99.8% | 行业排名> |
2023-03-31 | 85.49% | -1.02% | 0.76% | 14/158 | 52.78% | 迈威生物 | 99.46% | 行业排名> |
2022-12-31 | 84.85% | -0.42% | -0.35% | 15/158 | 53.66% | 迈威生物 | 99.75% | 行业排名> |
2022-09-30 | 85.14% | -1.21% | -0.07% | 12/158 | 6.2% | 迈威生物 | 99.67% | 行业排名> |
2022-06-30 | 85.2% | 0.6% | -1.35% | 12/158 | 21.37% | 迈威生物 | 99.44% | 行业排名> |
2022-03-31 | 86.37% | 1.6% | 1.37% | 12/158 | 54.28% | 迈威生物 | 98.57% | 行业排名> |
2021-12-31 | 85.21% | -0.88% | -1.14% | 19/158 | 55.1% | 首药控股 | 99.93% | 行业排名> |
2021-09-30 | 86.18% | -0.08% | 1.76% | 14/158 | 46.78% | 艾力斯 | 99.41% | 行业排名> |
2021-06-30 | 84.69% | 4.05% | -0.37% | 15/158 | 47.23% | 艾力斯 | 98.7% | 行业排名> |
2021-03-31 | 85.01% | 3.6% | -1.11% | 14/158 | 53.99% | 艾力斯 | 99.4% | 行业排名> |
2020-12-31 | 85.97% | 1.97% | -0.34% | 13/158 | -145.9% | 首药控股 | 99.94% | 行业排名> |
2020-09-30 | 86.26% | 2% | 5.97% | 11/158 | 56.36% | 泽璟制药 | 99.96% | 行业排名> |
2020-06-30 | 81.39% | -1.86% | -0.81% | 15/158 | 54.11% | 微芯生物 | 95.14% | 行业排名> |
2020-03-31 | 82.06% | 2% | -2.67% | 14/158 | 55.23% | 多瑞医药 | 95.59% | 行业排名> |
2019-12-31 | 84.3% | 3.82% | 1.65% | 12/158 | -1222.98% | 微芯生物 | 95.81% | 行业排名> |
2019-06-30 | 82.93% | 2% | 2.13% | 13/158 | 55.21% | 微芯生物 | 96.09% | 行业排名> |
2018-12-31 | 81.2% | 2.67% | 2.67% | 19/158 | -208.09% | 微芯生物 | 96.11% | 行业排名> |
2017-12-31 | 79.09% | 0.48% | 0.48% | 16/158 | 52.32% | 微芯生物 | 95.5% | 行业排名> |
2016-12-31 | 78.71% | 2% | 2% | 12/158 | 48.19% | 微芯生物 | 96.27% | 行业排名> |